Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Extensive Stage Small Cell Lung Cancer 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

durvalumab 1 ceralasertib 1 aflutinib 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Non Small Cell Lung Cancer NSCLC × ceralasertib × Clear all

NCT06680050 2025-12-18

AUSTRAL

Mario Negri Institute for Pharmacological Research

Phase 2 Recruiting

Non Small Cell Lung Cancer NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡